Abstract Details
|
Scott M. Belliston, DO
(Sanford)
PRESENTER |
Dr. Belliston has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. |
| No disclosure on file | |
| Sharon G. Lynch, MD, FAAN (Univ of Kansas Medical Center) | The institution of Dr. Lynch has received research support from National MS society. The institution of Dr. Lynch has received research support from PCORI. The institution of Dr. Lynch has received research support from Novartis. The institution of Dr. Lynch has received research support from Roche. The institution of Dr. Lynch has received research support from Chugai. The institution of Dr. Lynch has received research support from Sanofi. The institution of Dr. Lynch has received research support from Alexion. The institution of Dr. Lynch has received research support from EMD Serono. The institution of Dr. Lynch has received research support from Celgene. The institution of Dr. Lynch has received research support from Atara. The institution of Dr. Lynch has received research support from TG Therapeutics. The institution of Dr. Lynch has received research support from Medimmune. The institution of Dr. Lynch has received research support from Anokion. The institution of Dr. Lynch has received research support from Adamas. Dr. Lynch has a non-compensated relationship as a Board Memeber of the mid-America Chapter with National MS Society that is relevant to AAN interests or activities. Dr. Lynch has a non-compensated relationship as a President of Board of Directors with Friends of MS Achievement Center that is relevant to AAN interests or activities. |